Molecular epidemiological study of molluscum contagiosum virus in two urban areas of Western Japan by the in-gel endonuclease digestion method

1992 ◽  
Vol 125 (1-4) ◽  
pp. 339-345 ◽  
Author(s):  
J. Nakamura ◽  
Y. Arao ◽  
M. Yoshida ◽  
M. Yamada ◽  
S. Nii
Virology ◽  
1996 ◽  
Vol 226 (1) ◽  
pp. 95-101 ◽  
Author(s):  
Kenneth H. Fife ◽  
Margot Whitfeld ◽  
Holly Faust ◽  
Michael P. Goheen ◽  
Janine Bryan ◽  
...  

2011 ◽  
Vol 26 (S2) ◽  
pp. 1536-1536
Author(s):  
Z.-J. Zhang

Herb-drug interactions are an important issue in drug safety and clinical practice. The aim of this epidemiological study was to characterize associations of clinical outcomes with concomitant herbal and antipsychotic use in patients with schizophrenia. A total of 1795 patients with schizophrenia who were randomly selected from 17 psychiatric hospitals in China were interviewed face-to-face using a structured questionnaire. Association analyses were conducted to examine correlates between Chinese medicine (CM) use and demographic, clinical variables, antipsychotic medication mode, and clinical outcomes. The prevalence of concomitant CM and antipsychotic treatment was 36.4% [95% confidence interval (95% CI) 34.2%–38.6%]. Patients using concomitant CM had a significantly greater chance of improved outcomes than non-CM use (61.1% vs. 34.3%, OR = 3.44, 95% CI 2.80–4.24). However, a small but significant number of patients treated concomitantly with CM had a greater risk of developing worse outcomes (7.2% vs. 4.4%, OR = 2.06, 95% CI 2.06–4.83). Significant predictors for concomitant CM treatment-associated outcomes were residence in urban areas, paranoid psychosis, and exceeding 3 months of CM use. Herbal medicine regimens containing Radix Bupleuri, Fructus Gardenia, Fructus Schisandrae, Radix Rehmanniae, Akebia Caulis, and Semen Plantaginis in concomitant use with quetiapine, clozapine, and olanzepine were associated with nearly 60% of the risk of adverse outcomes. Our study suggests that concomitant herbal and antipsychotic treatment could produce either beneficial or adverse clinical effects in schizophrenic population. Potential herb-drug pharmacokinetic interactions need to be further evaluated.


1974 ◽  
Vol 24 (2) ◽  
pp. 237-246 ◽  
Author(s):  
G. Barbanti-Brodano ◽  
A. Mannini-Palenzona ◽  
O. Varoli ◽  
M. Portolani ◽  
M. La Placa

2018 ◽  
Vol 16 (9) ◽  
pp. 1144-1146
Author(s):  
Cornelia Sigrid Lissi Müller ◽  
Michael Laue ◽  
Kim Kremer ◽  
Stephanie Becker ◽  
Thomas Vogt ◽  
...  

2018 ◽  
Vol Volume 11 ◽  
pp. 2363-2375 ◽  
Author(s):  
Zhiyao Chen ◽  
Changlin Han ◽  
Xiaobin Huang ◽  
Yangqun Liu ◽  
Dan Guo ◽  
...  

1998 ◽  
Vol 73 (1) ◽  
pp. 83-87 ◽  
Author(s):  
Thierry Simonart ◽  
Jean-Christophe Noël ◽  
Jean-Paul Van Vooren ◽  
Philippe Hermans ◽  
Corine Liesnard ◽  
...  

2001 ◽  
Vol 30 (4) ◽  
pp. 206-212 ◽  
Author(s):  
M. J. Wilson ◽  
D. W. Williams ◽  
M. D. L. Forbes ◽  
I. G. Finlay ◽  
M. A. O. Lewis

2003 ◽  
Vol 41 (4) ◽  
pp. 1664-1672 ◽  
Author(s):  
H. Dabernat ◽  
M.-A. Plisson-Saune ◽  
C. Delmas ◽  
M. Seguy ◽  
G. Faucon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document